Free Trial
Ends Tomorrow! Last Chance to Save $100 on MarketBeat All Access
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Claim $100 Off
Claim MarketBeat All Access Sale Promotion

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
PureTech Health PLC Sponsored ADR stock logo
PRTC
PureTech Health
$17.42
$16.84
$14.50
$19.92
$424.04M1.1518,480 shsN/A
Invesco Variable Rate Preferred ETF stock logo
VRP
Invesco Variable Rate Preferred ETF
$24.26
+0.1%
$24.23
$23.71
$24.93
$2.59B0.31668,417 shs324,189 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
PureTech Health PLC Sponsored ADR stock logo
PRTC
PureTech Health
0.00%+0.17%-1.91%-2.58%-2.74%
Invesco Variable Rate Preferred ETF stock logo
VRP
Invesco Variable Rate Preferred ETF
0.00%-0.21%-0.29%-1.50%+0.83%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
PureTech Health PLC Sponsored ADR stock logo
PRTC
PureTech Health
$17.42
$16.84
$14.50
$19.92
$424.04M1.1518,480 shsN/A
Invesco Variable Rate Preferred ETF stock logo
VRP
Invesco Variable Rate Preferred ETF
$24.26
+0.1%
$24.23
$23.71
$24.93
$2.59B0.31668,417 shs324,189 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
PureTech Health PLC Sponsored ADR stock logo
PRTC
PureTech Health
0.00%+0.17%-1.91%-2.58%-2.74%
Invesco Variable Rate Preferred ETF stock logo
VRP
Invesco Variable Rate Preferred ETF
0.00%-0.21%-0.29%-1.50%+0.83%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
PureTech Health PLC Sponsored ADR stock logo
PRTC
PureTech Health
1.00
SellN/AN/A
Invesco Variable Rate Preferred ETF stock logo
VRP
Invesco Variable Rate Preferred ETF
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest BVXP, PRTC, HZD, and VRP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/18/2026
PureTech Health PLC Sponsored ADR stock logo
PRTC
PureTech Health
DowngradeSell (D)Sell (D-)
4/21/2026
PureTech Health PLC Sponsored ADR stock logo
PRTC
PureTech Health
Reiterated RatingSell (D)
(Data available from 5/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
PureTech Health PLC Sponsored ADR stock logo
PRTC
PureTech Health
$4.66M91.01N/AN/A$12.65 per share1.38
Invesco Variable Rate Preferred ETF stock logo
VRP
Invesco Variable Rate Preferred ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
PureTech Health PLC Sponsored ADR stock logo
PRTC
PureTech Health
-$109.74MN/AN/AN/AN/AN/AN/AN/AN/A
Invesco Variable Rate Preferred ETF stock logo
VRP
Invesco Variable Rate Preferred ETF
N/AN/AN/AN/AN/AN/AN/AN/AN/A

Latest BVXP, PRTC, HZD, and VRP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/10/2026H2 2025
PureTech Health PLC Sponsored ADR stock logo
PRTC
PureTech Health
N/A-$1.35N/A-$1.35N/A$1.40 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
PureTech Health PLC Sponsored ADR stock logo
PRTC
PureTech Health
N/AN/AN/AN/AN/A
Invesco Variable Rate Preferred ETF stock logo
VRP
Invesco Variable Rate Preferred ETF
$1.536.31%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
PureTech Health PLC Sponsored ADR stock logo
PRTC
PureTech Health
N/A
6.59
6.59
Invesco Variable Rate Preferred ETF stock logo
VRP
Invesco Variable Rate Preferred ETF
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
PureTech Health PLC Sponsored ADR stock logo
PRTC
PureTech Health
0.04%
Invesco Variable Rate Preferred ETF stock logo
VRP
Invesco Variable Rate Preferred ETF
N/A

Insider Ownership

CompanyInsider Ownership
PureTech Health PLC Sponsored ADR stock logo
PRTC
PureTech Health
5.30%
Invesco Variable Rate Preferred ETF stock logo
VRP
Invesco Variable Rate Preferred ETF
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
PureTech Health PLC Sponsored ADR stock logo
PRTC
PureTech Health
10024.34 million23.05 millionNot Optionable
Invesco Variable Rate Preferred ETF stock logo
VRP
Invesco Variable Rate Preferred ETF
N/A106.70 millionN/ANot Optionable

Recent News About These Companies

VRP: Preferred ETF With Outstanding Risk-Adjusted Return
Say No To Fixed-Rate Preferred Stocks With VRP
VRP: A Preferred ETF Looking Safer Than Its Peers
(VRP) Long Term Investment Analysis

Media Sentiment Over Time

PureTech Health stock logo

PureTech Health NASDAQ:PRTC

$17.42 0.00 (0.00%)
As of 05/22/2026

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies. It also develops SPT-300, an oral drug of allopregnanolone for the treatment of anxious depression; SPT-320, a novel prodrug of agomelatine for the treatment of generalized anxiety disorder; and SPT-348, a prodrug of a non-hallucinogenic neuroplastogen for the treatment of mood and other neuropsychiatric disorders. In addition, the company is developing hydrogels to enable the oral administration of peptide therapeutics in preclinical development. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.

Invesco Variable Rate Preferred ETF stock logo

Invesco Variable Rate Preferred ETF NYSEARCA:VRP

$24.26 +0.03 (+0.12%)
As of 05/22/2026 04:10 PM Eastern

The Invesco Variable Rate Preferred ETF (VRP) is an exchange-traded fund that mostly invests in broad credit fixed income. The fund tracks a market-value-weighted index of variable- and floating-rate preferred stocks. VRP was launched on May 1, 2014 and is managed by Invesco.